A Phase Ib/II Clinical Study in Patients With Refractory Chronic Cough

NCT06213363 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Refractory Chronic Cough

Interventions

DRUG: TCR1672 tablet

Sponsor

Beijing Tide Pharmaceutical Co., Ltd